Genesis Shockwave

Genesis Shockwave is a Singapore-incorporated joint venture between Genesis MedTech Group and Shockwave Medical formed to commercialize intravascular lithotripsy (IVL) products in mainland China. The company focuses on importing, marketing, and potentially locally developing and manufacturing Shockwave-branded coronary and peripheral IVL devices for the treatment of severely calcified cardiovascular disease. Its known product scope includes the Shockwave IVL System and related coronary and peripheral IVL catheters that received China NMPA approval. Genesis Shockwave appears to be an operating medtech commercialization vehicle rather than a traditional drug-development biotech company, with its strategic value centered on China market access, distribution, and localized manufacturing support.